Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR1900025947Phase 3Not yet recruiting
Phase 3, randomised, double-blind trial of isoflurane (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Pharmacokinetic parameters, MOAA/S score and 2 more. Planned start Mar 2019; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR1900025947.